(Q45867015)

17 December 2017

title

Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation (English)

1 reference

17 December 2017

1 reference

5

M K Brenner

1 reference

17 December 2017

Helen Heslop

4

object named as

H E Heslop

1 reference

17 December 2017

author name string

T Vu

1

1 reference

17 December 2017

G Carrum

2

1 reference

17 December 2017

G Hutton

3

1 reference

17 December 2017

R Kamble

6

1 reference

17 December 2017

language of work or name

English

0 references

publication date

2 April 2007

1 reference

17 December 2017

Bone Marrow Transplantation

published in

1 reference

17 December 2017

volume

39

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

705-709

1 reference

17 December 2017

A population-based study of primary human herpesvirus 6 infection

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Quantitative detection and differentiation of human herpesvirus 6 subtypes in bone marrow transplant patients by using a single real-time polymerase chain reaction assay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Herpesvirus DNA detection in cerebral spinal fluid: differences in clinical presentation between alpha-, beta-, and gamma-herpesviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Human herpesvirus 6 limbic encephalitis after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705666

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705666

1 reference

17 December 2017

Dimensions Publication ID

1031763683

0 references

1 reference

17 December 2017